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1. Introduction 
Cytochrome c was the first respiratory protein of 
mitochondria to be isolated in pure form. The water 
solubility and stability of this hemoprotein has made 
for ease of study and cytochrome c is one of the best 
characterized proteins in the cell. The primary struc- 
ture of cytochrome c from a multitude of different 
sources has been determined. The protein has been 
crystallized and three-dimensional structural informa- 
tion obtained by X-ray studies [l-3]. For tuna cyto- 
chrome c, the structure of the oxidized and reduced 
states of the protein have been determined and refined 
to 1 S-1.8 A; a resolution at which bond angles and 
bond lengths between individual atoms can be mea- 
sured [4]. In addition to these structural studies, 
there has been considerable work on the kinetics of 
electron transfer between cytochrome c and artificial 
electron donors and acceptors uch as ferrocyanide 
[5-l 01. Based on these experiments, precise mecha- 
nisms of electron transfer between small molecule 
electron donors and cytochrome chave been proposed 
[9-l 11. 
plex III and cytochrome c oxidase and considers the 
implications of these results for our understanding of 
the terminal steps in mitochondrial electron transport. 
2. Structure of oxidised and reduced cytochrome c 
Oxidised cytochrome c is a roughly spherical 
molecule with a diameter between 25 W and 30 A 
[4]. The heme is located in a hydrophobic pocket or 
cleft, extending to the surface on what Dickerson and 
colleagues call the front face of the protein [ 11. Sur- 
rounding the heme cleft are a number of lysine resi- 
dues. This ring of positive charges i  conserved in all 
of the cytochromes c for which sequence data is 
available [ 121. 
The physiological electron donor and acceptor for 
cytochrome c in mitochondria re ubiquinone cyto- 
chrome c reductase (complex III) and cytochrome c
oxidase (complex IV), respectively. These intrinsic 
membrane complexes have proved much more dif- 
ficult to isolate and characterize than cytochrome c
and only recently has it been possible to study the 
interaction of cytochrome c with either of these 
proteins. This review collects some of the recent 
observations on the binding of cytochrome c to com- 
The structure of reduced cytochrome c is remark- 
ably similar to the oxidised form [4]. Significant 
differences occur .only near a buried water molecule 
which is hydrogen-bonded to Asn 52, Tyr 67 and Thr 
78. This water molecule is 1 .O A further from the 
heme in the reduced protein and the heme is 0.15 A 
more buried in the heme crevice [4]. Thus the heme 
is in a less polar environment in reduced cytochrome 
c. The similarity in the structures of the oxidised and 
reduced forms of cytochrome c is consistent with the 
nearly identical binding constants of the two redox 
forms with cytochrome c oxidase [13,14]. 
3. Binding sites for complex III and cytochrome c 
ox&se on cytochrome c 
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chrome c. Individual lysines on cytochrome c have 
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been modified to replace the positively charged 
amino group with a neutral trifluoroacetyl [15 ] or 
(trifluoromethyl) phenylcarbamoyl group [ 161 or 
with a negatively charged carboxydinitrophenyl 
group [ 17,181. The effect of these modifications on 
electron transfer with reductases and oxidases has 
then been compared [15-l 81. Modification of any of 
lysines 8,13,25,27,72,79,86 or 87 affected activity 
with either complex III or cytochrome c oxidase. 
Alteration of other lysines had a minimal effect on 
activity. The above-listed positively charged residues 
are the conserved amino acids around the heme 
cleft [4]. 
The finding that.cytochrome c uses the same or a 
very similar binding site for interaction with complex 
III and cytochrome c oxidase has been confirmed by 
a different approach. Rieder and Bosshard have 
shown that the same lysine residues (8 ,13,72,73,86 
and 87) are shielded from acetylation by complexing 
cytochrome c with either the reductase or oxidase 
[ 19,201. Fig.1 shows the binding site for complex III 
and cytochrome coxidase as determined by the above 
studies. 
The same site is involved in interaction with other 
A 
oxidases and reductases, for example, cytochrome c
peroxidase [21,22], cytochrome bs [23] and sulfite 
oxidase [24,25]. The three-dimensional structure of 
both cytochrome b5 [26] and cytochrome c per- 
oxidase [27] is known from X-ray crystallography. It 
has been possible, therefore, to computer-fit the cyto- 
chrome c-cytochrome b5 and cytochrome c-cyto- 
chrome c peroxidase pairs to look for sites on cyto- 
chrome b5 and cytochrome c peroxidase that are 
complementary to the highly positively charged 
region on cytochrome c [28,29]. In both cases there 
is a negatively charged region complementary to the 
positively charged residues near the heme cleft of 
cytochrome c. The interaction between cytochrome 
c and cytochrome b 5 through these complementary 
binding sites would bring the two hemes within 8.5 A 
of each other and in parallel orientation [28]. In the 
hypothetical cytochrome c-cytochrome c peroxi- 
dase complex, the hemes are 16.5 A apart (edge to 
edge) and again are parallel [29]. 
Presumably, cytochrome cl of complex III and 
subunit II of cytochrome c oxidase (see later) will 
contain a ring of negatively charged residues which 
act as the binding site for cytochrome c. 
B 
Fig.1. Schematic of the binding domain on cytochrome c for interaction with cytochrome c oxidase (A) and complex III (B). The 
number of diagonal hatchmarks in each circle is proportional to the contribution of that lysine to the electrostatic interaction 
(reproduced from [ 161 with permission). 
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4. Movement of cytochrome c between complex III 
and cytochrome c oxidase 
The fact that the site of entry and exit of electrons 
to and from cytochrome c involves the same site 
argues for dissociation of cytochrome c from the high 
affinity site on the reductase before binding to the 
oxidase. Cytochrome c could remain attached to the 
reductase, the oxidase, or to a complex between oxi- 
dase and reductase and still transfer electrons, provided 
that rotational movement within a limited domain is 
allowed. Alternatively, cytochrome c could dissociate 
from the reductase and move to the oxidase through 
lateral diffusion across the surface of the membrane. 
The possibility that complex III, cytochrome c
and cytochrome c oxidase form a supramolecular 
aggregate has been examined in reconstitution exper- 
iments. Kawato et al. [30] have shown that the rate 
of rotational diffusion of cytochrome c oxidase in 
reconstituted vesicles is the same whether or not 
complex III and cytochrome c are present. If these 
components formed a stable aggregate, the rate would 
have been slower in the presence of complex III by a 
factor of 2 or 3. Kawato et al. [30] conclude that 
cytochrome c shuttles between complex III and cyto- 
chrome c oxidase by lateral diffusion along the mem- 
brane [30]. 
5. Number of binding sites and affmities for cytochrome 
c in mitochondria 
Complex III has been found to contain a single 
binding site for cytochrome c per monomer with high 
affinity .(Kd Y 10 -13 M) [ 171. This site has been 
localized by chemical crosslinking to cytochrome cl, 
a hemoprotein of Mr - 30 000 [3 11. 
The interaction of cytochrome c with cytochrome 
c oxidase is more complicated than with complex III. 
There are 2 binding sites for this substrate per cyto- 
chrome c oxidase monomer under conditions of low 
ionic strength, one with a high affinity (Kd N 10-a M), 
the other with 50-IOO-fold lower affinity [ 18,321. 
Both sites are important for cytochrome c oxidase 
activity as evident from kinetic studies. Fig.2 shows 
an &die-Hofstee plot of the activity of beef-heart 
cytochrome c oxidase when assayed polarographically 
[with N,iV,N’,N’-tetramethylhyl-phenylenediamine 
(TMPD) and ascorbate as electron donors]. Two 
phases of activity are seen with api. Km 10-a M 
Fig.2. Eadie-Hofstee plots of cytochrome c oxidase activity 
measured polarographically with TMPD and ascorbate as 
electron donors. The different plots are for preparations of
enzyme containing different amounts of tightly bound phos- 
pholipid as foBows: (A-A) 30 ccg/mg; (O-0) 21 Mg/mg; 
(o-•) 10 gg/mg; (m----¤.) 2 pg/mg (reproduced from [45] 
with permission). 
and 1O-6 M, respectively. These have been interpreted 
as involving electron transfer through the high and 
low affinity sites, respectively [ 18,321 (but see sec- 
tion 8 for alternative interpretations of the kinetic 
data). The lipid bilayer also provides negatively 
charged sites for interaction with cytochrome c [33]. 
These are of lower affinity (lo-’ M) than sites on 
proteins but are in much greater numbers. Thus cyto- 
chrome c released from complex 111 and cytochrome 
c oxidase should be retained on the membrane sur- 
face rather than being free in the intracristal space. 
6. Structure of cytochrome c bin&g sites on 
cytochrome c oxidase 
The locus of the high affinity site for cytochrome 
3 
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c on cytochrome c oxidase has been characterized by 
crosslinking experiments [34-391. Two cytochrome 
c derivatives have been particularly useful in this 
regard. One involves the modification of lysine 13 of 
horse heart cytochrome c with a photoactive aryl- 
azido-group, which upon illumination with UV light, 
inserts into a nearest nucleophilic group [36]. The 
arylazidocytochrome c derivative has been shown to 
bind to beef heart cytochrome c oxidase in the high 
affinity site and insert exclusively into subunit II 
[36,37]. Sequencing studies have further localized the 
site of binding of this derivative to a segment of sub- 
unit II around His 161 (R. Bisson, G. C. M. Steffens, 
G. Buse, R. A; C., unpublished). 
The second derivative used was TNB-cytochrome 
c, a derivative of yeast cytochrome c in which Cys 
107 has been modified by a thionitrobenzoate group 
[38,39]. TNB is a good leaving roup and promotes 
disultide bond formation between Cys 107 and any 
near neighbor cysteine. The TNB-cytochrome c 
derivative has been shown to bind to beef-heart cyto- 
chrome c oxidase in the high affinity site and link 
covalently in subunit III rather than subunit II [38]. 
TNB-Cytochrome c has also been covalently cross- 
linked to yeast cytochrome c oxidase through sub- 
unit III [39]. This subunit from both yeast and beef- 
heart cytochrome c oxidase contains 2 cysteines 
(S. Anderson, personal communication; [40]). How- 
ever, only one of these is conserved and this is Cys 
115 (numbering in beef heart subunit III), which is, 
therefore, almost certainly the site of interaction of 
the TNB-cytochrome c. 
Cytochrome c derivatives modified at the front 
(Lys 13) and back (Cys 107) can only bind into the 
(same) high affinity site of cytochrome c oxidase if 
the site is a large cleft almost he diameter of the 
cytochrome c molecule. Subunit II must form one 
face of this cleft and subunit III another. A cleft of 
the right size is evident on the C (cytoplasmic) 
domain of cytochrome c oxidase as visualized by elec- 
tron microscopy and image reconstruction studies 
(fig.3). This cleft is on the 2-fold axis between mono- 
mers of the cytochrome c oxidase dimer and each 
high affinity site includes ubunit II of one monomer 
and subunit III of an opposing monomer. The interac- 
tion between the front face of cytochrome c and sub- 
unit II must provide the majority of the binding 
energy because, as discussed already, chemical modifi- 
cation of lysines on the back side of cytochrome c do 
not greatly affect the activity. Only when the modifi- 
4 
Fig.3. Schematic of the high affinity binding site(s) for cyto- 
chrome c in the cytochrome c oxidase dimer. The shape of 
the cytochrome c oxidase monomer and relationship of 
monomers in the dimer is taken from [43,48]. The position 
of 2 cytochrome c molecules in the 2 high affmity sites per 
dimer are shown. The linkage of arylazido-cytochrome c to 
subunit II is represented (-) arrow: the linkage of the TNB- 
cytochrome c to subunit III by -S. 
cation of the side or back is large enough to sterically 
hinder the approach of cytochrome c to the cleft, is 
there a major effect, as seen for example in antibody 
binding experiments [41]. 
The possibility that the high affinity site is in the 
interface between monomers allows an explanation of 
the observed ‘half-of-site’ effect of the arylazido- 
cytochrome c derivative on cytochrome c oxidase 
activity [37]. Similar behavior has been found for 
other dimeric or oligomeric proteins on binding of 
substrate analogues at the monomer-monomer inter- 
face and this phenomenon does not necessarily have 
any physiological significance [42]. Experiments 
with the covalently-linked yeast cytochrome c have 
shown that the monomers of the dimeric beef enzyme 
function independently in electron transfer [39]. 
Experiments are in progress to determine the locus 
of the high affinity binding site within the cytochrome 
c oxidase dimer more directly. Two-dimensional 
crystals of cytochrome c oxidase have been obtained 
using deoxycholate as a detergent in which the oxi- 
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dase molecules are present as monomers [43]. The 
arylazidocytochrome c derivative has been covalently 
bound to these preparations without perturbing their 
crys&lline state. Fab fragments specific for cytochrome 
c have then been bound to the lattice in order to 
locate the site of binding of cytochrome cwith respect 
to the cytochrome c oxidase molecule. Preliminary 
results indicate that cytochrome c is indeed bound to 
that surface of the cytochrome c oxidase molecule 
which is involved in dimer formation [44]. Inter- 
estingly, the TNB-cytochrome c derivative does not 
bind to the monomeric ytochrome c oxidase in these 
crystalline preparations (S. D. Fuller, unpublished). 
The most likely explanation is that the specific inter- 
action between the front face of cytochrome c and 
the oxidase molecule (on one monomer) is necessary 
to bring the Cys 107 in position for disulflde bond 
formation with subunit III (in the second monomer). 
(If subunits II and III of the same monomer were 
involved, crosslinking of the TNB-cytochrome c 
should not be affected by the aggregation state of 
cytochrome c oxidase.) 
7. Identification of the low affinity site for cytoehrome 
c in cytochrome c oxidase 
Cytochrome cbinding to beef heart cytochrome c
oxidase has been found to depend on the lipid com- 
position of the enzyme preparation [45]. Enzyme 
containing high concentrations of phospholipid 
@20 mol/mol) binds 3 or more cytochrome c mole- 
cules in low ionic strength buffer and at high concen- 
trations of cytochrome c. As lipid is progressively 
removed, the amount of cytochrome c that can be 
bound becomes lower. Cytochrome c oxidase con- 
taining 4 or 5 molecules of tightly bound cardiolipin 
binds only 2 cytochrome c molecules, one in the high 
affinity site, the second in the low affinity site (Kd u 
1 0m6 M) [45]. As these cardiolipin molecules are 
progressively removed, the number of cytochrome c
molecules bound is reduced to one and the low affinity 
phase of electron transfer also disappears (fig.2). 
These results indicate that negatively charged phos- 
pholipids contribute an Important part of the low 
affinity binding site (see also [46]). 
8. Function of the high and low affmity sites for 
cytochrome c or cytochrome c oxidase 
The various chemical crosslinking studies have 
allowed the analysis of the roles of the high and low 
affinity sites for cytochrome c in cytochrome c oxi- 
dase activity. The covalent complexes between either 
arylazidocytochrome c or the TNB yeast cytochrome 
c derivatives and cytochrome c oxidase were inactive 
in the spectrophotometric assay when reduced cyto- 
chrome c was used as a substrate [37,39]. If blocking 
the high affinity sites inhibits activity completely, 
there can be no independent electron transfer through 
the low affinity sites, as proposed [18,321. 
Electron transfer can occur through the high 
affinity binding site without cytochrome c in the 
low affinity site. Lipid free cytochrome c oxidase 
retains activity although the low affinity site has 
been lost [43]. Also, a complex with TNB-cyto- 
chrome c covalently bound to cytochrome c oxidase 
in the high affinity site is active in electron transfer 
with artificial electron donors as substrate in the 
absence of cytochrome c in the low affinity site [39]. 
However, electron transfer without the low affinity 
site is much less than maximal, being 1 O-20% for 
lipid free enzyme and a maximum of 15% of optimal 
for the TNB-cytochrome c-cytochrome c oxidase 
complex. 
We have described 3 possible mechanisms by 
which cytochrome c in the low affinity site can 
increase lectron transfer [39]: 
(1) Binding of cytochrome c molecules in the low 
affinity site decreases the affinity of cytochrome c in 
the high affinity site, so increasing the rate of electron 
transfer. 
(2) Electron transfer proceeds through both the 
high and low affinity sites but with transfer through 
the low affinity site occurring only after an electron 
has entered the oxidase through the high affmity site. 
(3) Binding of cytochrome c to the low affinity site 
increases the intramolecular rate of electron transfer, 
e.g., by increasing the rate of electron transfer from 
the a,Cu, couple to the as,CuOs couple. 
Any of the above mechanisms would explain the 
2 phases of activity seen in the Eadie-Hofstee plots 
shown in fig.2. Wilms et al. [47] have measured the 
off-rate of cytochrome c from the high affinity site 
to be 2 s-l in the absence of this substrate in the low 
affinity site. They have shown that binding a positively 
charged protein in the low affinity site increases this 
off-rate at least SO-fold, in support of mechanism (1). 
5 
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9. Summary and description of the steps in electron 
transfer from complex III to cytochrome c oxidase 
The studies reviewed above suggest a model for 
electron transfer from complex III to cytochrome c
oxidase with the following steps: 
(i) Reduced cytochrome c dissociates from com- 
plex III before it can bind to cytochrome c oxidase. 
This follows from the fact that cytochrome chas the 
same binding domain for reductases and oxidases. 
(ii) Electron transfer from complex III to cyto- 
chrome c oxidase occurs by lateral diffusion of cyto- 
chrome c across the surface of the membrane. 
(iii) Reduced cytochrome c transfers into the low 
affinity site of cytochrome c oxidase which involves 
tightly bound cardiolipin. 
(iv) Binding of cytochrome c in the low affinity 
site then effects the release of cytochrome c from the 
high affinity site either by charge repulsion or by con- 
formational rearrangements in the cytochrome c oxi- 
dase molecule (mechanism (1) from section 8). 
(v) Reduced cytochrome c in the low affinity site 
transfers into the high affinity site and gives up its 
electron to cytochrome c oxidase. Oxidized cyto- 
chrome c would be replaced by another educed cyto- 
chrome c and the process occurs 4 times for each 
turnover of cytochrome c oxidase in the overall 
reaction: 
4 H’ + 4 cytochrome c2* + O2 2 
2 Hz0 t 4 cytochrome c3*. 
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